Methods Study to Evaluate Use of Cardiac Ultrasound to Assess Heart Valve Abnormality in People.
Completed
- Conditions
- Heart Valve Diseases
- Registration Number
- NCT00359489
- Lead Sponsor
- Pfizer
- Brief Summary
Methods study to evaluate use of cardiac ultrasound to assess heart valve abnormality in people.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- >=18 years of age subjects with stable concomitant diseases with BMI >=30 kg/m2
Read More
Exclusion Criteria
- Pregnant females
- Those with unstable/new onset diseases
- Those who are on agents known to be associated with cardiac valvular heart disease
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pfizer Investigational Site
🇺🇸New Haven, Connecticut, United States